These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34958805)

  • 1. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.
    Chen C; Cui P; Zhao K; Niu G; Hou S; Zhao D; Zeng H
    Microvasc Res; 2022 Mar; 140():104305. PubMed ID: 34958805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
    Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
    Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors.
    Cui P; Liu X; Zhao K; Hou S; Chen C; Zhao D; Zeng H
    Microvasc Res; 2020 May; 129():103955. PubMed ID: 31733305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.
    Liu X; Zhao D; Qin L; Li J; Zeng H
    J Biol Chem; 2008 Dec; 283(49):34159-67. PubMed ID: 18840614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
    Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H
    Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor.
    Liu X; Zhao D; James L; Li J; Zeng H
    FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
    Shin J; Lee JC; Baek KH
    Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.
    Xu Y; Yang B; Hu Y; Lu L; Lu X; Wang J; Shu Q; Cheng Q; Yu S; Xu F; Huang J; Liang X
    Mol Neurobiol; 2017 Oct; 54(8):6556-6571. PubMed ID: 27734335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
    Gollogly LK; Ryeom SW; Yoon SS
    J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
    Yao YG; Duh EJ
    Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
    Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
    Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells.
    Chen C; Li Y; Hou S; Bourbon PM; Qin L; Zhao K; Ye T; Zhao D; Zeng H
    Microvasc Res; 2020 Mar; 128():103934. PubMed ID: 31654655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down syndrome candidate region 1,a downstream target of VEGF, participates in endothelial cell migration and angiogenesis.
    Iizuka M; Abe M; Shiiba K; Sasaki I; Sato Y
    J Vasc Res; 2004; 41(4):334-44. PubMed ID: 15263820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
    Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers.
    Bartolomé RA; Torres S; Isern de Val S; Escudero-Paniagua B; Calviño E; Teixidó J; Casal JI
    Oncotarget; 2017 Jan; 8(1):215-227. PubMed ID: 27966446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
    Hesser BA; Liang XH; Camenisch G; Yang S; Lewin DA; Scheller R; Ferrara N; Gerber HP
    Blood; 2004 Jul; 104(1):149-58. PubMed ID: 15016650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
    Baek KH; Zaslavsky A; Lynch RC; Britt C; Okada Y; Siarey RJ; Lensch MW; Park IH; Yoon SS; Minami T; Korenberg JR; Folkman J; Daley GQ; Aird WC; Galdzicki Z; Ryeom S
    Nature; 2009 Jun; 459(7250):1126-30. PubMed ID: 19458618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-329 upregulation impairs the HMGB2/β-catenin pathway and regulates cell biological behaviors in melanoma.
    Mo Y; Fang RH; Wu J; Si Y; Jia SQ; Li Q; Bai JZ; She XN; Wang JQ
    J Cell Physiol; 2019 Dec; 234(12):23518-23527. PubMed ID: 31219186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry.
    Liu R; Cao Z; Tu J; Pan Y; Shang B; Zhang G; Bao M; Zhang S; Yang P; Zhou Q
    Pigment Cell Melanoma Res; 2012 Sep; 25(5):630-8. PubMed ID: 22781316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.